What is the maintenance therapy for gout after the acute phase?

The maintenance therapy for gout after the acute phase is allopurinol. Allopurinol is a xanthine oxidase inhibitor that decreases the production of uric acid in the body, effectively lowering uric acid levels. This reduction helps prevent future gout flares by maintaining uric acid levels within a normal range.

During the acute phase of gout, nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin or naproxen, as well as colchicine, may be utilized to manage pain and inflammation. However, these medications are not suitable for long-term management. Allopurinol, on the other hand, is specifically designed for long-term use to control hyperuricemia (excess uric acid in the bloodstream) and is the established standard for preventing recurrent attacks of gout.

In summary, after addressing the acute symptoms of gout, transitioning to allopurinol as a maintenance therapy is essential for long-term management and prevention of further episodes.